Dentons has advised the shareholders of Meopta Group, a manufacturer of optical, opto-mechanical, and opto-electronic solutions, in connection with the sale of the company to Global investment firm Carlyle (NASDAQ: CG). The terms of the transaction were not disclosed.

With the acquisition of Meopta, Carlyle will seek to support the company’s growth in partnership with its management team by diversifying its mix of end markets and customers, capturing the opportunity in more advanced built-to-spec use cases through an increased focus on R&D, capitalizing on attractive opportunities in a diverse range of end markets and expanding its international presence through the creation of a direct sales network, and improving its operations.

“It’s been an absolute pleasure to support the Rausnitz family and Meopta in achieving this milestone. We’ve been very impressed with the Meopta team and are excited to see what they can further accomplish with the backing of Carlyle”, said Rob Irving, Co-Head of the Europe Corporate Group.

“Such transactions showcase our capabilities to help market leading European industrial technology companies such as Meopta in their development and growth in Central and Eastern Europe and beyond”, added Petr Zákoucký, Czech Republic Managing Partner and Co-Head of the Corporate/M&A practice in Dentons’ Prague office.

Partner Evan Lazar added, “We are thrilled that Dentons’ cross-practice teams across Europe, UK and US were able to support the Rausnitz family in this strategic partnership.”